ARCT · Arcturus Therapeutics Holdings Inc. · Executive Compensation

$9.84 -0.89 (-8.29%) At close · Oct 23

Russell 2000 member Rebalance outlook locked

Market Cap

$285.23M

28.42M

Volume · Oct 23 475K Avg daily vol (3M) 939.9K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Payne	CEO	$750,000	—	—	$941,000	—	—	$1,691,000
Joseph E. Payne	President and Chief Executive Officer, Director	$750,000	—	—	$941,000	—	—	$1,691,000
Andy Sassine	Former Chief Financial Officer	$572,000	—	—	$37,500	—	$572,000	$1,181,500
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$572,000	—	—	$290,000	—	—	$862,000
Lance Kurata	Chief Legal Officer	$540,000	—	—	$290,000	—	—	$830,000
Joe Roberts	Interim Principal Financial Officer and Accounting Officer; Controller	$219,580	—	—	$54,000	—	—	$273,580

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Payne	CEO	$695,000	$367,000	—	$2,635,000	—	—	$3,697,000
Joseph E. Payne	President and Chief Executive Officer, Director	$695,000	$367,000	—	$2,635,000	—	—	$3,697,000
Andy Sassine	Chief Financial Officer, Director	$550,000	$261,000	—	$807,000	—	—	$1,618,000
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$550,000	$228,000	—	$807,000	—	—	$1,585,000
Lance Kurata	Chief Legal Officer	$500,000	$180,000	—	$807,000	—	—	$1,487,000
Joe Roberts	Interim Principal Financial Officer and Accounting Officer; Controller	$211,130	$38,010	—	$156,589	—	—	$405,729

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph E. Payne	President and Chief Executive Officer, Director	$698,000	$208,500	—	$3,986,000	—	—	$4,892,500
Joseph Payne	CEO	$698,000	$208,500	—	$3,986,000	—	—	$4,892,500
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$550,000	$137,500	—	$2,491,000	—	—	$3,178,500
Andy Sassine	Chief Financial Officer, Director	$550,000	$137,500	—	$1,495,000	—	—	$2,182,500
Lance Kurata	Chief Legal Officer	$500,000	$100,000	—	$1,495,000	—	—	$2,095,000
Joe Roberts	Interim Principal Financial Officer and Accounting Officer; Controller	$182,000	$16,390	—	$149,484	—	—	$347,874

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph E. Payne	President and Chief Executive Officer, Director	$630,000	$504,000	—	$4,460,000	—	—	$5,594,000
Joseph Payne	CEO	$630,000	$504,000	—	$4,460,000	—	—	$5,594,000
Andy Sassine	Chief Financial Officer, Director	$525,000	$301,875	—	$2,318,500	—	—	$3,145,375
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$525,000	$262,500	—	$2,318,500	—	—	$3,106,000
Lance Kurata	Chief Legal Officer	$435,000	$304,500	—	$442,500	—	—	$1,182,000

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Payne	CEO	$600,000	$360,000	—	—	—	—	$960,000
Joseph E. Payne	President and Chief Executive Officer, Director	$600,000	$360,000	—	—	—	—	$960,000
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$500,000	$250,000	—	—	—	—	$750,000
Andy Sassine	Chief Financial Officer, Director	$500,000	$250,000	—	—	—	—	$750,000
Dr. Steven Hughes	Former Chief Medical Officer	$460,000	$184,000	—	—	—	—	$644,000
Lance Kurata	Chief Legal Officer	$400,000	$160,000	—	—	—	—	$560,000

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph E. Payne	President and Chief Executive Officer, Director	$500,000	$450,000	—	$11,911,500	—	—	$12,861,500
Joseph Payne	CEO	$500,000	$450,000	—	$11,911,500	—	—	$12,861,500
Andy Sassine	Chief Financial Officer	$400,000	$240,000	—	$7,014,800	—	—	$7,654,800
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$400,000	$240,000	—	$6,832,600	—	—	$7,472,600
Lance Kurata	Chief Legal Officer	$156,250	$67,500	—	$4,916,800	—	—	$5,140,550
Dr. Steven Hughes	Former Chief Medical Officer	$415,000	$249,000	—	$4,212,625	—	—	$4,876,625

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andy Sassine	Chief Financial Officer	$375,000	$150,000	—	$801,880	—	—	$1,326,880
Joseph Payne	CEO	$450,000	$243,000	—	$472,818	—	—	$1,165,818
Joseph E. Payne	President and Chief Executive Officer, Director	$450,000	$243,000	—	$472,818	—	—	$1,165,818
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$370,000	$133,200	—	$132,956	—	—	$636,156
Dr. Steven Hughes	Former Chief Medical Officer	$299,873	$249,000	—	—	—	—	$299,873

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Payne	CEO	$425,000	$372,532	—	$636,888	—	$1,252,624	$2,687,044
Joseph E. Payne	President and Chief Executive Officer, Director	$425,000	$372,532	—	$636,888	—	$1,252,624	$2,687,044
Padmanabh Chivukula	Chief Scientific Officer, Chief Operating Officer	$350,000	$83,233	—	$424,592	—	$515,080	$1,372,905
Andy Sassine	Chief Financial Officer	$120,000	—	—	$126,340	—	—	$246,340

Executive changes

Person	Role	Change	Effective	Filed
Dennis Mulroy	Chief Financial Officer	Appointed	2026-05-01	2026-05-07
Joe Roberts	interim principal accounting officer	Appointed	2025-12-12	2025-12-15
Andy Sassine	member of the Company's Board of Directors	Resigned	2025-12-11	2025-12-15
Joe Roberts	interim principal financial officer	Appointed	2025-12-12	2025-12-15
Andy Sassine	Chief Financial Officer	Resigned	2025-12-31	2025-12-15
Dr. Moncef Slaoui	member of the Board of Directors	Appointed	2024-06-19	2024-06-24
Dr. John H. Markels	Director	Appointed	2024-06-14	2024-06-14
Dr. Jing L. Marantz	Director	Appointed	2024-06-14	2024-06-14
Dr. Magda Marquet	Director	Appointed	2024-06-14	2024-06-14
James Barlow	Director	Appointed	2024-06-14	2024-06-14
Dr. Edward W. Holmes	Director	Appointed	2024-06-14	2024-06-14
Andy Sassine	Director	Appointed	2024-06-14	2024-06-14
Joseph E. Payne	Director	Appointed	2024-06-14	2024-06-14
Dr. Peter Farrell	Director	Appointed	2024-06-14	2024-06-14
Keith C. Kummerfeld	Senior Vice President of Finance and Corporate Controller	Resigned	2024-03-15	2024-02-23
John Markels	member of the Board of Directors	Appointed	2022-12-08	2022-12-13

Leadership

Joseph E. Payne CEO, Board Member
Joseph Payne CEO, Board Member
Andy Sassine CFO, Board Member
Dennis Mulroy CFO
Joe Roberts CFO, Chief Accounting Officer
Padmanabh Chivukula COO
Dr. Edward W. Holmes Board Member
Dr. Jing L. Marantz Board Member
Dr. Jing Marantz Board Member
Dr. John H. Markels Board Member
Dr. Magda Marquet Board Member
Dr. Moncef Slaoui Board Member
Dr. Moncef Slaoui, Ph.D. Board Member
Dr. Peter Farrell Board Member
James Barlow Board Member
John Markels Board Member

Key facts CIK 1768224 CUSIP 03969T109 13F (30d) 19 filings 19 filers Visit website Investor relations